EVOKE PHARMA INC's ticker is and the CUSIP is 30049G203. A total of 11 filers reported holding EVOKE PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 5,793 | $7,994 | 0.00% |
| Concord Wealth Partners | 31 | $43 | 0.00% |
| CWM, LLC | 16 | $0 | 0.00% |
| ROYAL BANK OF CANADA | 28 | $0 | 0.00% |
| VANGUARD GROUP INC | 29,851 | $41,194 | 0.00% |
| UBS Group AG | 2,707 | $3,736 | 0.00% |
| NewEdge Advisors, LLC | 208 | $287 | 0.00% |
| WELLS FARGO & COMPANY/MN | 24 | $33 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 27,065 | $37,079 | 0.00% |
| BlackRock Inc. | 1,473 | $2,032 | 0.00% |
This page lists EVOKE PHARMA INC's shareholders in Q3 2023. To view EVOKE PHARMA INC's shareholder history, click here.